Type 2 diabetes Trials in Kingsport, United States
Conditions / Type 2 diabetes / Kingsport, United States
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02019264 | A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors | COMPLETED | PHASE4 |
| NCT00643851 | An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets | COMPLETED | PHASE3 |
| NCT06221969 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor | COMPLETED | — |
| NCT06323174 | A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise | COMPLETED | PHASE3 |
| NCT02227875 | Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) | COMPLETED | PHASE3 |
| NCT01606007 | Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT01609582 | Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease | TERMINATED | PHASE3 |
| NCT00683878 | Add-on to Thiazolidinedione (TZD) Failures | COMPLETED | PHASE3 |
| NCT01624259 | A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00528372 | A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | COMPLETED | PHASE3 |